On May 31, 2021 Vaccibody AS, a clinical-stage biopharmaceutical company dedicated to the discovery and development of vaccines and novel immunotherapies, reported that its CEO, Michael Engsig, and Chief Innovation & Strategy Officer, Agnete Fredriksen, Ph.D., will give a presentation of Vaccibody at the Jefferies Virtual Healthcare Conference at 4.30 pm CET / 10.30 am EDT on June 2, 2021 (Press release, Vaccibody, MAY 31, 2021, View Source/wp-content/uploads/2021/06/210531_PR_Jefferies-Virtual-Healthcare-Conference-June-1-4-2021-FINAL.pdf" target="_blank" title="View Source/wp-content/uploads/2021/06/210531_PR_Jefferies-Virtual-Healthcare-Conference-June-1-4-2021-FINAL.pdf" rel="nofollow">View Source [SID1234583303]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The presentation will be available on Vaccibody’s website at View Source